Pediatric psychopharmacology in primary care: a conceptual framework

Adolesc Med State Art Rev. 2013 Aug;24(2):371-90, vii.

Abstract

In a 2009 policy statement focused on children's mental health, the American Academy of Pediatrics recommended that pediatric primary care physicians achieve competence in initiating care for children with attention-deficit/hyperactivity disorder (ADHD), anxiety, depression, and substance use/abuse. Because treatment for 3 of these conditions--ADHD, anxiety, and depression--may, under certain conditions, include medication, the primary purpose of this article is to offer guidance to assist primary care physicians in decision-making about their use of psychotropic medications for these conditions. A few medications with proven efficacy and safety are emphasized. Secondarily, other medications that may be useful for other disorders are noted.

Publication types

  • Review

MeSH terms

  • Adolescent
  • Anxiety / diagnosis
  • Anxiety / drug therapy
  • Attention Deficit Disorder with Hyperactivity / diagnosis
  • Attention Deficit Disorder with Hyperactivity / drug therapy
  • Central Nervous System Agents / pharmacology*
  • Central Nervous System Agents / therapeutic use*
  • Child
  • Depression / diagnosis
  • Depression / drug therapy
  • Drug Therapy, Combination
  • Humans
  • Informed Consent
  • Mental Disorders / diagnosis
  • Mental Disorders / drug therapy*
  • Primary Health Care*
  • Psychopharmacology*
  • Risk Factors
  • Suicide

Substances

  • Central Nervous System Agents